| 1 |
원자력안전법 (원자력안전위원회, 2022.04.20)./
|
|
| 2 |
PriceJackson. PhD. Radiation Dosimetry in 177 Lu-PSMA-617 Therapy. Seminars in Nuclear Medicine. Volume 52, Issue 2, March 2022, Pages 243-254/
|
|
| 3 |
John Kennedy. Ph.D. Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy. Seminars in Nuclear Medicine.Volume 52, Issue 2, March 2022, Pages 229-242/
|
|
| 4 |
Sherman S.M, Sim J, Cutts M, Dasch H, Amlot R, Rubin G.J, et al. COVID-19 vaccination acceptability in the UK at the start of the vaccination programme: a nationally representative cross-sectional survey(CoVAccS - wave 2). Public Health, Voulume 202. January 2022:1-9/
|
|
| 5 |
Zhang M, Richard W. Ahn, Jody C. Hayes, Stephen J. Seiler, et al. Axillary Lymphadenopathy in the COVID-19 Era: What the Radiologist Needs to know. RadioGraphics. 26 Aug 2022:42:0000-0000/
|
|
| 6 |
Qian K, Tomoki Arichi, Anthony Price, Sofia Dall'Orso, Jonathan Eden, Yohan Noh, An eye tracking based virtual reality system for use inside magnetic resonance imaging systems, Scientific Reports, 2021;11(1):1-2/
|
|
| 7 |
M Lassmann, U Eberlein, J Tran-Gia. Multicentre Trials on standardised quantitative imaging and dosimetry for radionuclide therapies. Clin Oncol (R Coll Radiol), 33 (2021), pp. 125-130/
|
|
| 8 |
Shah S, Wagner T, Nathan M, Szyszko T. COVID-19 vaccine-related lymph node activation- patterns of uptake on PET-CT, British Institute of Radiology. 20 Apr 2021: Vol 7, No. 3./
|
|
| 9 |
Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT. Korean J Radiol. 2021 Dec; 22(12): 1938 -1945./
|
|
| 10 |
Kim SJ, Kim EJ, The Use of Virtual Reality in Psychiatry: A Review. Korean Academy of Child and Adolescent Psychiatry, 2020;31(1):26-32/
|
|